Repurposing of Thalidomide as a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study. International Journal of Research in Pharmaceutical Sciences and Technology, [S. l.], v. 9, n. 3, 2026. DOI: 10.33974/st7x9s50. Disponível em: http://rubatosisjournals.com/index.php/ijrpst/article/view/589. Acesso em: 10 aug. 2026.